NCT07123103
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07123103
Title A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Exelixis
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Exelixis Clinical Site #5 RECRUITING Rogers Arkansas 72758 United States Details
Exelixis Clinical Site #9 RECRUITING Los Angeles California 90033 United States Details
Exelixis Clinical Site #6 RECRUITING Washington D.C. District of Columbia 20057 United States Details
Exelixis Clinical Site #4 RECRUITING Orlando Florida 32827 United States Details
Exelixis Clinical Site #3 RECRUITING Grand Rapids Michigan 49546 United States Details
Exelixis Clinical Site #7 RECRUITING New Brunswick New Jersey 08901 United States Details
Exelixis Clinical Site #2 RECRUITING Huntersville North Carolina 28078 United States Details
Exelixis Clinical Site #8 RECRUITING Houston Texas 77030 United States Details
Exelixis Clinical Site #1 RECRUITING San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field